胸腹主动脉瘤开窗与分支支架腔内修复术中麻醉类型与临床结局的关联
本研究为单中心回顾性观察研究,纳入2014至2021年124例择期行开窗/分支支架腔内修复术的胸腹主动脉瘤患者,比较全身麻醉(GA)与监测麻醉监护(MAC)的短期结局。倾向评分匹配后GA组与MAC组各42例,两组心脏及非心脏并发症无差异,但GA组需使用正性肌力药或血管加压药者更多(33% vs 9%,p=.031)。麻醉类型似乎对手术成功、围术期并发症及死亡率无影响。
要点
- 倾向评分匹配后GA组与MAC组各42例,心脏及非心脏并发症无差异。
- GA组需正性肌力药或血管加压药者比例高于MAC组(33% vs 9%,p=.031)。
- 住院死亡率4%,GA组与MAC组无差异(2% vs 5%,p=1.0)。
核心结论
- 麻醉类型似乎对F/BEVAR患者的手术成功、围术期并发症或死亡率无影响。
研究设计与样本
- 单中心、回顾性、观察性研究,连续纳入2014至2021年124例择期行开窗/分支支架腔内修复术的胸腹主动脉瘤患者。
主要发现
- 倾向评分匹配后GA组42例与MAC组42例,两组心脏及非心脏并发症无差异。
- GA组需正性肌力药或血管加压药者比例高于MAC组(33% vs 9%,p=.031)。
- GA组与MAC组30天技术成功率分别为81%与83%(p=.078)。
- GA组与MAC组主要不良事件发生率分别为10%与12%(p=.72),两组间无显著差异。
- GA组与MAC组一年再干预率分别为14%与21%(p=.39),一年靶血管不稳定率分别为10%与21%(p=.39),两组间无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although endovascular repair of thoraco-abdominal aortic aneurysm (TAAA) is the treatment of choice in the high risk population that is ineligible for an open surgical approach, little is known about the association between the type of anaesthesia and complications. This study compared the short term clinical outcomes of patients undergoing the visceral step of TAAA with fenestrated endograft aortic repair (FEVAR) and branched endograft aortic repair (BEVAR) under general anaesthesia (GA) with sedation with monitored care anaesthesia (MAC). METHODS: This single centre, retrospective, observational study recruited 124 consecutive patients undergoing elective F/BEVAR from 2014 - 2021. The primary endpoint was the short term complication rate according to the type of anaesthesia. Secondary endpoints included: need for inotropes or vasopressors for hypotension, time spent in the operating room, and admission to the intensive care unit. Propensity score matching was generated to account for the between group imbalance in the pre-operative covariables. RESULTS: After propensity score matching, 42 patients under GA were matched with 42 under MAC. The two groups showed no difference in cardiac and non-cardiac complications. Among the secondary outcomes, a higher number of patients in the GA group required inotropes or vasopressors compared with MAC (33% vs. 9%; p = .031). Although GA and MAC showed the same 30 day technical success (81% vs. 83%; p = .078), non-significant lower rates of major adverse events (10% vs. 12%; p = .72), one year re-intervention (14% vs. 21%; p = .39), and one year target vessel instability (10% vs. 21%; p = .39) were observed in the GA group. Overall, the in hospital mortality rate was 4%, with no difference between GA and MAC (2% vs. 5%; p = 1.0). CONCLUSION: The type of anaesthesia seemed to have no effect on procedure success, peri-operative morbidity, or mortality in patients undergoing F/BEVAR.
引用
- Monaco F, Barucco G, Licheri M, et al. Association Between Type of Anaesthesia and Clinical Outcome in Patients Undergoing Endovascular Repair of Thoraco-Abdominal Aortic Aneurysms by Fenestrated and Branched Endografts. Eur J Vasc Endovasc Surg. 2022. PMID: 35853581. doi:10.1016/j.ejvs.2022.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。